Assistant Professor
Specialization: Pharmacognosy
Qualifications: M.Pharm, Ph.D
Experience: 12 years
Research Profiles:
Google Scholar: https://scholar.google.com/citations?user=ZnNlAucAAAAJ&hl=en&authuser=1
ResearchGate: https://www.researchgate.net/profile/Prasanth-Dintakurthi
Scopus: https://www.scopus.com/authid/detail.uri?authorId=56641599900
ORCID: https://orcid.org/my-orcid?orcid=0000-0001-5028-1283
Web of Science: https://www.webofscience.com/wos/author/record/R-8562-2019
Brief Bio:
Dr. DSNBK Prasanth, currently serving as an Assistant Professor in the Department of Pharmacognosy at SPTM, SVKM's NMIMS Deemed to be University, Hyderabad. Dr. Prasanth secured AIR 198 in GPAT 2013. With 12 years of experience in academia and research, he has published more than 40 Scopus Indexed research and review articles in peer-reviewed national and international journals, with a highest impact of 13.1. He is currently supervising three PhD research scholars.
Interest Areas:
Research:
Publications: 40 (SCI & Scopus Indexed)
Books: 1
Patents: 12 (Published: 5; Granted: 7)
Scopus and SCI Publications: Cumulative Impact Factor: 105.816
[1] Vamshi G, Prasanth DSNBK, Sampath A, Dammalli M, Kumar P, B.S G, et al. Possible cerebroprotective effect of citronellal: molecular docking, MD simulation and in vivo investigations. Journal of Biomolecular Structure and Dynamics. 2024;42(3):1208-1219. doi:10.1080/07391102.2023.2220025. (Scopus & SCI Indexed) (Impact Factor: 4.4; Q1)
[2] Prasanth D, Reddy LSS, Dasari T, Bhavanam PR, Ahmad SF, Nalluri R, et al. LC/MS-Based Profiling of Hedyotis aspera Whole-Plant Methanolic Extract and Evaluation of Its Nephroprotective Potential against Gentamicin-Induced Nephrotoxicity in Rats Supported by In Silico Studies. Separations. 2023;10(11). doi:10.3390/separations10110552. (Scopus & SCI Indexed) (Impact Factor: 2.6; Q2)
[3] Pavani K, Prasanth DSNBK, Shadakshara MKR, Ahmad SF, Seemaladinne R, Rudrapal M, et al. Citronellal as a Promising Candidate for Alzheimer’s Disease Treatment: A Comprehensive Study on In Silico and In Vivo Anti-Acetylcholine Esterase Activity. Metabolites. 2023;13(11). doi:10.3390/metabo13111133. (Scopus & SCI Indexed) (Impact Factor: 4.1; Q2)
[4] Panda SP, Prasanth D, Gorla US, Dewanjee S. Interlinked role of ASN, TDP-43 and Miro1 with parkinopathy: Focus on targeted approach against neuropathy in parkinsonism. Ageing Research Reviews. 2023;83. doi:10.1016/j.arr.2022.101783. (Scopus & SCI Indexed) (Impact Factor: 13.1; Q1)
[5] Lakshmi YS, Prasanth DSNBK, Kumar KTS, Ahmad SF, Ramanjaneyulu S, Rahul N, et al. Unravelling the Molecular Mechanisms of a Quercetin Nanocrystal for Treating Potential Parkinson’s Disease in a Rotenone Model: Supporting Evidence of Network Pharmacology and In Silico Data Analysis. Biomedicines. 2023;11(10). doi:10.3390/biomedicines11102756. (Scopus & SCI Indexed) (Impact Factor: 4.7; Q1)
[6] Kumar RN, Prasanth D, Midthuri PG, Ahmad SF, Badarinath AV, Karumanchi SK, et al. Unveiling the Cardioprotective Power: Liquid Chromatography–Mass Spectrometry (LC–MS)-Analyzed Neolamarckia cadamba (Roxb.) Bosser Leaf Ethanolic Extract against Myocardial Infarction in Rats and In Silico Support Analysis. Plants. 2023;12(21). doi:10.3390/plants12213722. (Scopus & SCI Indexed) (Impact Factor: 4.5; Q1)
Professional Memberships:
